Clinical Trial Update: Study to Compare VMP With HDM Followed by VRD Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Multiple Myeloma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating VMP with high-dose melphalan followed by VRD consolidation and lenalidomide maintenance in newly diagnosed multiple myeloma has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Melphalan (Melphalan)
• PREDNISONE (Prednisone)
• Revlimid (lenalidomide)
• Velcade (bortezomib)

Snippet

Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED